Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cerebellar neurons are the primary cellular components of the cerebellum, a brain region essential for motor coordination, precision, and timing (StatPearls, 2023, https://www.ncbi.nlm.nih.gov/books/NBK538163/). This population includes inhibitory Purkinje cells, which serve as the sole output of the cerebellar cortex, and excitatory granule cells, the most abundant neurons in the mammalian brain (Wikipedia, 2024, https://en.wikipedia.org/wiki/Cerebellum). These neurons are involved in the pathophysiology of various conditions, most notably spinocerebellar ataxias, where neuronal degeneration leads to significant motor impairment (Mayo Clinic, 2023, https://www.mayoclinic.org/diseases-conditions/ataxia/symptoms-causes/syc-20355652). While not a single molecular target, cerebellar neurons express a high density of specific receptors, such as GABA-A receptors and P/Q-type voltage-gated calcium channels, which are the actual targets for drugs treating epilepsy and movement disorders (PubMed, 2021, https://pubmed.ncbi.nlm.nih.gov/33454567/). Therapeutic strategies often focus on modulating the firing patterns of these neurons or protecting them from excitotoxicity and oxidative stress. Dysfunction in these cells is also increasingly linked to non-motor conditions, including autism spectrum disorders and cognitive deficits. Understanding the unique physiological properties of these neurons is critical for developing treatments that can restore motor function or prevent neurodegeneration.
Modulation of neuronal excitability through interaction with GABAergic receptors, glutamate receptors, and voltage-gated ion channels.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cerebellar neurons.